[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Global & USA Checkpoint Inhibitors for Treating Cancer Market Research by Company, Type & Application 2015-2026

June 2021 | 81 pages | ID: CA9FFCD32C04EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
HeyReport estimates that the Checkpoint Inhibitors for Treating Cancer market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.

In this report, HeyReport discusses the Global & USA industrial policies, economic environment, and the impact of covid-19 on the Checkpoint Inhibitors for Treating Cancerindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.

Market Segment as follows:

Product Type Segmentation Includes
  • PD-1 inhibitors
  • PD-L1 inhibitors
  • CTLA-4 inhibitors
Application Segmentation Includes
  • Melanoma treatment
  • Bladder cancer treatment
  • Others
Companies Includes
  • Bristol-Myers Squibb(BMS)
  • Merck
  • Roche
The main contents of the report including:

Section 1:
Product definition, type and application, Global & USA market overview;
Section 2:
Global & USA Market competition by company;
Section 3:
Global & USA sales revenue, volume and price by type;
Section 4:
Global & USA sales revenue, volume and price by application;
Section 5:
USA export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact HeyReport for customized contents.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 PD-1 inhibitors
    1.1.2.2 PD-L1 inhibitors
    1.1.2.3 CTLA-4 inhibitors
  1.1.3 Market by Application
    1.1.3.1 Melanoma treatment
    1.1.3.2 Bladder cancer treatment
    1.1.3.3 Others
1.2 Global & USA Market Size & Forecast
  1.2.1 Global Market (2015-2020 & 2021-2026)
  1.2.2 USA Market (2015-2020 & 2021-2026)

2 GLOBAL & USA MARKET BY COMPANY

2.1 Global Sales by Company
2.2 USA Sales by Company

3 GLOBAL & USA MARKET BY TYPE

3.1 Global Sales by Product Type
3.2 USA Sales by Product Type

4 GLOBAL & USA MARKET BY APPLICATION

4.1 Global Sales by Application
4.2 USA Sales by Application

5 USA TRADE

5.1 Export Overview
5.2 Import Overview

6 KEY COMPANIES LIST

6.1 Bristol-Myers Squibb(BMS)
  6.1.1 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Merck
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Roche
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Upstream Overview

8 POLICIES & MARKET ENVIRONMENT

8.1 Policies
  8.1.1 Major Regions Policies
  8.1.2 Policies in USA
8.2 Market Environment
  8.2.1 Porter's Five Forces
  8.2.2 Impact of COVID-19

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2015-2020
Table Global Market Sales Revenue Share by Company 2015-2020
Table Global Market Sales Volume by Company 2015-2020
Table Global Market Sales Volume Share by Company 2015-2020
Table Global Price by Company 2015-2020
Table USA Market Sales Revenue by Company 2015-2020
Table USA Market Sales Revenue Share by Company 2015-2020
Table USA Market Sales Volume by Company 2015-2020
Table USA Market Sales Volume Share by Company 2015-2020
Table USA Price by Company 2015-2020
Table Global Market Sales Revenue by Type 2015-2020
Table Global Market Sales Revenue Share by Type 2015-2020
Table Global Market Sales Volume by Type 2015-2020
Table Global Market Sales Volume Share by Type 2015-2020
Table Global Price by Type 2015-2020
Table USA Market Sales Revenue by Type 2015-2020
Table USA Market Sales Revenue Share by Type 2015-2020
Table USA Market Sales Volume by Type 2015-2020
Table USA Market Sales Volume Share by Type 2015-2020
Table USA Price by Type 2015-2020
Table Global Market Sales Revenue by Application 2015-2020
Table Global Market Sales Revenue Share by Application 2015-2020
Table Global Market Sales Volume by Application 2015-2020
Table Global Market Sales Volume Share by Application 2015-2020
Table Global Price by Application 2015-2020
Table USA Market Sales Revenue by Application 2015-2020
Table USA Market Sales Revenue Share by Application 2015-2020
Table USA Market Sales Volume by Application 2015-2020
Table USA Market Sales Volume Share by Application 2015-2020
Table USA Price by Application 2015-2020
Table USA Export 2015-2020 (Million USD)
Table USA Export 2015-2020 (Volume)
Table USA Import 2015-2020 (Million USD)
Table USA Import 2015-2020 (Volume)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Roche


LIST OF FIGURES

Figure PD-1 inhibitors Market Size and Growth 2015-2020 (Million USD)
Figure PD-1 inhibitors Market Size and Growth 2015-2020 (Volume)
Figure PD-1 inhibitors Market Forecast and Growth 2021-2026 (Million USD)
Figure PD-1 inhibitors Market Forecast and Growth 2021-2026 (Volume)
Figure PD-L1 inhibitors Market Size and Growth 2015-2020 (Million USD)
Figure PD-L1 inhibitors Market Size and Growth 2015-2020 (Volume)
Figure PD-L1 inhibitors Market Forecast and Growth 2021-2026 (Million USD)
Figure PD-L1 inhibitors Market Forecast and Growth 2021-2026 (Volume)
Figure CTLA-4 inhibitors Market Size and Growth 2015-2020 (Million USD)
Figure CTLA-4 inhibitors Market Size and Growth 2015-2020 (Volume)
Figure CTLA-4 inhibitors Market Forecast and Growth 2021-2026 (Million USD)
Figure CTLA-4 inhibitors Market Forecast and Growth 2021-2026 (Volume)
Figure Melanoma treatment Market Size and Growth 2015-2020 (Million USD)
Figure Melanoma treatment Market Size and Growth 2015-2020 (Volume)
Figure Melanoma treatment Market Forecast and Growth 2021-2026 (Million USD)
Figure Melanoma treatment Market Forecast and Growth 2021-2026 (Volume)
Figure Bladder cancer treatment Market Size and Growth 2015-2020 (Million USD)
Figure Bladder cancer treatment Market Size and Growth 2015-2020 (Volume)
Figure Bladder cancer treatment Market Forecast and Growth 2021-2026 (Million USD)
Figure Bladder cancer treatment Market Forecast and Growth 2021-2026 (Volume)
Figure Others Market Size and Growth 2015-2020 (Million USD)
Figure Others Market Size and Growth 2015-2020 (Volume)
Figure Others Market Forecast and Growth 2021-2026 (Million USD)
Figure Others Market Forecast and Growth 2021-2026 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2020 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2020 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and Growth 2021-2026 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and Growth 2021-2026 (Volume)
Figure USA Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2020 (Million USD)
Figure USA Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2020 (Volume)
Figure USA Checkpoint Inhibitors for Treating Cancer Market Forecast and Growth 2021-2026 (Million USD)
Figure USA Checkpoint Inhibitors for Treating Cancer Market Forecast and Growth 2021-2026 (Volume)
Figure Global Market Sales Revenue Share by Company in 2019
Figure Global Market Sales Volume Share by Company in 2019
Figure USA Market Sales Revenue Share by Company in 2019
Figure USA Market Sales Volume Share by Company in 2019
Figure Global Market Sales Revenue Share by Type in 2019
Figure Global Market Sales Volume Share by Type in 2019
Figure USA Market Sales Revenue Share by Type in 2019
Figure USA Market Sales Volume Share by Type in 2019
Figure Global Market Sales Revenue Share by Application in 2019
Figure Global Market Sales Volume Share by Application in 2019
Figure USA Market Sales Revenue Share by Application in 2019
Figure USA Market Sales Volume Share by Application in 2019
Figure Industry Chain Overview


More Publications